AR049274A1 - Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2 - Google Patents
Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2Info
- Publication number
- AR049274A1 AR049274A1 ARP050101914A ARP050101914A AR049274A1 AR 049274 A1 AR049274 A1 AR 049274A1 AR P050101914 A ARP050101914 A AR P050101914A AR P050101914 A ARP050101914 A AR P050101914A AR 049274 A1 AR049274 A1 AR 049274A1
- Authority
- AR
- Argentina
- Prior art keywords
- substantially pure
- phenylpiridin
- methylaminopirimidin
- acid2
- ilamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57014604P | 2004-05-12 | 2004-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049274A1 true AR049274A1 (es) | 2006-07-12 |
Family
ID=34969825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050101914A AR049274A1 (es) | 2004-05-12 | 2005-05-11 | Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2 |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1747215A1 (pt) |
| JP (1) | JP2007537266A (pt) |
| KR (1) | KR20070011483A (pt) |
| CN (1) | CN1950359A (pt) |
| AR (1) | AR049274A1 (pt) |
| AU (1) | AU2005245834A1 (pt) |
| BR (1) | BRPI0511029A (pt) |
| CA (1) | CA2566213A1 (pt) |
| EC (1) | ECSP066992A (pt) |
| GT (1) | GT200500111A (pt) |
| IL (1) | IL178992A0 (pt) |
| MA (1) | MA28553B1 (pt) |
| MX (1) | MXPA06012870A (pt) |
| NO (1) | NO20065719L (pt) |
| PA (1) | PA8633101A1 (pt) |
| PE (1) | PE20060269A1 (pt) |
| RU (1) | RU2006143758A (pt) |
| SV (1) | SV2006002111A (pt) |
| TN (1) | TNSN06338A1 (pt) |
| TW (1) | TW200605881A (pt) |
| UY (1) | UY28897A1 (pt) |
| WO (1) | WO2005113544A1 (pt) |
| ZA (1) | ZA200608712B (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19951360A1 (de) | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
| DE102004033406A1 (de) | 2004-07-10 | 2006-02-16 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung der enantiomeren Formen von 2,3-Diaminopropionsäurederivaten |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| CN104491864A (zh) | 2008-04-21 | 2015-04-08 | 奥德纳米有限公司 | 用于治疗耳部疾病和病况的耳用调配物及方法 |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2011134140A1 (en) * | 2010-04-27 | 2011-11-03 | Hutchison Medipharma Limited | Pyrimidinyl indole compounds |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| AU2017290256A1 (en) | 2016-06-29 | 2019-01-17 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
| CN106588803A (zh) * | 2016-11-16 | 2017-04-26 | 西南科技大学 | 一种制备5‑乙酰基异噁唑的新方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10237722A1 (de) * | 2002-08-17 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase |
-
2005
- 2005-05-11 PE PE2005000524A patent/PE20060269A1/es not_active Application Discontinuation
- 2005-05-11 KR KR1020067023661A patent/KR20070011483A/ko not_active Application Discontinuation
- 2005-05-11 AU AU2005245834A patent/AU2005245834A1/en not_active Abandoned
- 2005-05-11 CA CA002566213A patent/CA2566213A1/en not_active Abandoned
- 2005-05-11 CN CNA200580015046XA patent/CN1950359A/zh active Pending
- 2005-05-11 RU RU2006143758/04A patent/RU2006143758A/ru not_active Application Discontinuation
- 2005-05-11 AR ARP050101914A patent/AR049274A1/es not_active Application Discontinuation
- 2005-05-11 EP EP05749733A patent/EP1747215A1/en not_active Withdrawn
- 2005-05-11 WO PCT/US2005/016381 patent/WO2005113544A1/en active Application Filing
- 2005-05-11 BR BRPI0511029-7A patent/BRPI0511029A/pt not_active IP Right Cessation
- 2005-05-11 JP JP2007513292A patent/JP2007537266A/ja not_active Abandoned
- 2005-05-11 GT GT200500111A patent/GT200500111A/es unknown
- 2005-05-11 MX MXPA06012870A patent/MXPA06012870A/es not_active Application Discontinuation
- 2005-05-12 UY UY28897A patent/UY28897A1/es unknown
- 2005-05-12 SV SV2005002111A patent/SV2006002111A/es not_active Application Discontinuation
- 2005-05-12 PA PA20058633101A patent/PA8633101A1/es unknown
- 2005-05-12 TW TW094115316A patent/TW200605881A/zh unknown
-
2006
- 2006-10-18 ZA ZA200608712A patent/ZA200608712B/en unknown
- 2006-10-18 TN TNP2006000338A patent/TNSN06338A1/en unknown
- 2006-10-27 MA MA29415A patent/MA28553B1/fr unknown
- 2006-11-01 IL IL178992A patent/IL178992A0/en unknown
- 2006-11-10 EC EC2006006992A patent/ECSP066992A/es unknown
- 2006-12-12 NO NO20065719A patent/NO20065719L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06012870A (es) | 2007-02-15 |
| PE20060269A1 (es) | 2006-05-11 |
| RU2006143758A (ru) | 2008-06-27 |
| GT200500111A (es) | 2006-05-09 |
| TW200605881A (en) | 2006-02-16 |
| AU2005245834A1 (en) | 2005-12-01 |
| UY28897A1 (es) | 2005-12-30 |
| EP1747215A1 (en) | 2007-01-31 |
| ZA200608712B (en) | 2008-06-25 |
| BRPI0511029A (pt) | 2007-11-27 |
| TNSN06338A1 (en) | 2008-02-22 |
| WO2005113544A1 (en) | 2005-12-01 |
| JP2007537266A (ja) | 2007-12-20 |
| CN1950359A (zh) | 2007-04-18 |
| CA2566213A1 (en) | 2005-12-11 |
| NO20065719L (no) | 2006-12-12 |
| PA8633101A1 (es) | 2006-01-23 |
| IL178992A0 (en) | 2007-03-08 |
| MA28553B1 (fr) | 2007-04-03 |
| ECSP066992A (es) | 2006-12-29 |
| KR20070011483A (ko) | 2007-01-24 |
| SV2006002111A (es) | 2006-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049274A1 (es) | Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2 | |
| AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
| PE20121820A1 (es) | (2s,3r)-n-(2-((3-piridinil)metil)-1-azabiciclo[2.2.2]oct-3-il)benzofuran-2-carboxamida, formas de sales novedosas de ella, y metodos de uso de ella | |
| AR049681A1 (es) | Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas | |
| AR058085A1 (es) | Sal de dihidrogeno fosfato de un antagonista del receptor de prostaglandina d2. composiciones farmaceuticas. | |
| AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
| ECSP099436A (es) | Acilaminopirazoles como inhibidores de fgfr | |
| ECSP11010948A (es) | Inhibidores de las enzimas de proteína cinasa activadas por | |
| BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
| SE0202463D0 (sv) | Novel compounds | |
| ECSP044992A (es) | Inhibidores de la alquín-aril fosfodiesterasa-4 | |
| RS52534B (en) | MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS | |
| ATE479687T1 (de) | Kinaseinhibitoren | |
| RS53209B (en) | PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS C PROTEASE INHIBITOR | |
| PA8591701A1 (es) | Derivados de pirrolopirimidina | |
| ES2422557T3 (es) | Compuestos y composiciones como moduladores de la ruta Hedgehog | |
| RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
| MX2009005048A (es) | Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona. | |
| ECSP11011065A (es) | Composición farmacéutica de un potente inhibidor de hcv para su administración oral | |
| AR058904A1 (es) | Proceso mejorado para la preparacion de un derivado de 5h-pirrolo[3,4-b] pirazina opticamente activo | |
| MX2009011579A (es) | Pirimidinonas como moduladores de caseina cinasa ii (ck2). | |
| AR061134A1 (es) | Derivados de tioxantina | |
| SE0302324D0 (sv) | Novel compounds | |
| WO2007011878A8 (en) | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists | |
| CL2007001752A1 (es) | Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |